Cited by 132Primary Care and Health OutcomesClinical practice guidelines implementationBlood Pressure and Hypertension Studies

Reasons for not intensifying medications: differentiating “clinical inertia” from appropriate care

Open access
Safford, Monika M., Shewchuk, Richard, Qu, Haiyan, Williams, Jessica H., Estrada, Carlos A., Ovalle, Fernando, Allison, Jeroan J.·2007·Journal of General Internal Medicine

Abstract

Background "Clinical inertia" has been defined as inaction by physicians caring for patients with uncontrolled risk factors such as blood pressure. Some have proposed that it accounts for up to 80% of cardiovascular events, potentially an important quality problem. However, reasons for so-called clinical inertia are poorly understood.Objective To derive an empiric conceptual model of clinical inertia as a subset of all clinical inactions from the physician perspective.Methods We used Nominal Group panels of practicing physicians to identify reasons why they do not intensify medications when seeing an established patient with uncontrolled blood pressure.Measurements and main results We stopped at 2 groups (N = 6 and 7, respectively) because of the high degree of agreement on reasons for not intensifying, indicating saturation. A third group of clinicians (N = 9) independently sorted the reasons generated by the Nominal Groups. Using multidimensional scaling and hierarchical cluster analysis, we translated the sorting results into a cognitive map that represents an empirically derived model of clinical inaction from the physician's perspective. The model shows that much inaction may in fact be clinically appropriate care.Conclusions/recommendations Many reasons offered by physicians for not intensifying medications suggest that low rates of intensification do not necessarily reflect poor quality of care. The empirically derived model of clinical inaction can be used as a guide to construct performance measures for monitoring clinical inertia that better focus on true quality problems.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11606-007-0433-8

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Numerous studies have demonstrated the clinical benefits of early achievement of near-normal glycemic control in individuals with type 1 diabetes and type 2 diabetes.

    “Numerous studies have demonstrated the clinical benefits of early achievement of nearnormal glycemic control in individuals with type 1 diabetes and type 2 diabetes (77-83).”

    From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [78]

    The Introduction (page unavailable) mentions clinical inertia in diabetes, but does not discuss the benefits of early, near-normal glycemic control. Searches for that phrase and for glycemic-control benefits found no passage addressing the claimed benefits in type 1 or type 2 diabetes. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Safford, M. M., Shewchuk, R., Qu, H., Williams, J. H., Estrada, C. A., Ovalle, F., & Allison, J. J.
Affiliations
University of Alabama at Birmingham (US)
Corresponding author
Safford, Monika M.
Venue
Journal of General Internal Medicine
Published
2007-10-24
Volume
22
Issue
12
Pages
1648-1655
ISSN
  • 0884-8734 (ISSN-L)
  • 1525-1497
OpenAlex
W2058108073
Cited by
132
References
28
Citations by year
2026: 6 · 2024: 8 · 2023: 5 · 2021: 5 · 2020: 5 · 2019: 8 · 2018: 5 · 2017: 12 · 2016: 9 · 2015: 3 · 2014: 10 · 2013: 7 · 2012: 10
FWCI
15.80
Type
journal article
Language
en
Open access
Locations
  • Journal of General Internal Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R18DK065001, R18DK65001-01A2)
Topics
  • Health Sciences › Health Professions › General Health Professions › Primary Care and Health Outcomes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
clinical inertia, medication intensification, uncontrolled hypertension, physician decision-making, quality of care, cardiovascular risk factors, performance indicators, cognitive maps, nominal group technique
MeSH terms
Adult, Antihypertensive Agents, Blood Pressure, Drug Utilization, Female, Humans, Hypertension, Male, Middle Aged, Models, Theoretical, Motivation, Physician-Patient Relations, Practice Patterns, Physicians', Primary Health Care, Risk Factors, Guideline Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review